Prognostic value of pretreatment 18F-FDG PET-CT in radiotherapy for patients with hepatocellular carcinoma |
Jo, In Young
(Department of Radiation Oncology, the Catholic University of Korea College of Medicine)
Son, Seok-Hyun (Department of Radiation Oncology, the Catholic University of Korea College of Medicine) Kim, Myungsoo (Department of Radiation Oncology, the Catholic University of Korea College of Medicine) Sung, Soo Yoon (Department of Radiation Oncology, the Catholic University of Korea College of Medicine) Won, Yong Kyun (Department of Radiation Oncology, the Catholic University of Korea College of Medicine) Kang, Hye Jin (Department of Radiation Oncology, the Catholic University of Korea College of Medicine) Lee, So Jung (Department of Radiation Oncology, the Catholic University of Korea College of Medicine) Chung, Yong-An (Department of Radiology, the Catholic University of Korea College of Medicine) Oh, Jin Kyoung (Department of Radiology, the Catholic University of Korea College of Medicine) Kay, Chul-Seung (Department of Radiation Oncology, the Catholic University of Korea College of Medicine) |
1 | Lee JH, Kim DH, Ki YK, et al. Three-dimensional conformal radiotherapy for portal vein tumor thrombosis alone in advanced hepatocellular carcinoma. Radiat Oncol J 2014;32:170-8. DOI |
2 | Khan MA, Combs CS, Brunt EM, et al. Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatol 2000;32:792-7. |
3 | Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer 2011;11:85-95. DOI |
4 | Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108. DOI |
5 | El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011;365:1118-27. DOI |
6 | Saraswat VA, Pandey G, Shetty S. Treatment algorithms for managing hepatocellular carcinoma. J Clin Exp Hepatol 2014;4:S80-9. |
7 | Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003;362:1907-17. DOI |
8 | Kim SW, Oh D, Park HC, et al. Transcatheter arterial chemoembolization and radiation therapy for treatment-naive patients with locally advanced hepatocellular carcinoma. Radiat Oncol J 2014;32:14-22. DOI |
9 | Kim JW, Seong J, Yun M, et al. Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in predicting treatment response in unresectable hepatocellular carcinoma patients treated with external beam radiotherapy. Int J Radiat Oncol Biol Phys 2012;82:1172-8. DOI |
10 | Shiomi S, Nishiguchi S, Ishizu H, et al. Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma. Am J Gastroenterol 2001;96:1877-80. DOI |
11 | Gomaa AI, Al-Khatib A, Abdel-Razek W, Hashim MS, Waked I. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging. World J Gastroenterol 2015;21:5654-62. DOI |
12 | Pressiani T, Boni C, Rimassa L, et al. Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis. Ann Oncol 2013;24:406-11. DOI |
13 | Pant V, Sen IB, Soin AS. Role of (1)(8)F-FDG PET CT as an independent prognostic indicator in patients with hepatocellular carcinoma. Nucl Med Commun 2013;34:749-57. DOI |
14 | Koom WS, Seong J, Han KH, Lee DY, Lee JT. Is local radiotherapy still valuable for patients with multiple intrahepatic hepatocellular carcinomas? Int J Radiat Oncol Biol Phys 2010;77:1433-40. DOI |
15 | Park W, Lim DH, Paik SW, et al. Local radiotherapy for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2005;61:1143-50. DOI |
16 | Cartier V, Aube C. Diagnosis of hepatocellular carcinoma. Diagn Interv Imaging 2014;95:709-19. DOI |
17 | Trevisani F, D'Intino PE, Morselli-Labate AM, et al. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol 2001;34:570-5. DOI |
18 | Huang YJ, Hsu HC, Wang CY, et al. The treatment responses in cases of radiation therapy to portal vein thrombosis in advanced hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2009;73:1155-63. DOI |
19 | Seong J, Park HC, Han KH, et al. Local radiotherapy for unresectable hepatocellular carcinoma patients who failed with transcatheter arterial chemoembolization. Int J Radiat Oncol Biol Phys 2000;47:1331-5. DOI |
20 | Park H, Kim SU, Park JY, et al. Clinical usefulness of double biomarkers AFP and PIVKA-II for subdividing prognostic groups in locally advanced hepatocellular carcinoma. Liver Int 2014;34:313-21. DOI |
21 | Daniele A, Divella R, Quaranta M, et al. Clinical and prognostic role of circulating MMP-2 and its inhibitor TIMP-2 in HCC patients prior to and after trans-hepatic arterial chemoembolization. Clin Biochem 2014;47:184-90. DOI |
22 | Jun CH, Sim DW, Kim SH, et al. Predictive factors for recurrence and survival in hepatocellular carcinoma in South Korea. Anticancer Res 2013;33:4129-34. |
23 | Torizuka T, Tamaki N, Inokuma T, et al. In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET. J Nucl Med 1995;36:1811-7. |